The present solution provides a solid oral pharmaceutical formulation containing ticagrelor in the chemical name (1S 2S 3R 5S) 3 [7 [[(1R 2S) 2 (3 4 difluorophenyl)cyclopropyl]amino] 5 (propylthio) 3H 1 2 3 triazolo[4 5 d]pyrimidin 3 yl] 5 (2 hydroxyethoxy) 1 2 cyclopentanediol comprising at least one non hygroscopic filler and/or at least one non hygroscopic binder wherein neither the filler nor the binder have any disintegration effect. Preparation of the formulation is possible by wet granulation or dry granulation or direct
